FOXA2 Rewires AP-1 for Transcriptional Reprogramming and Lineage Plasticity in Prostate Cancer

Investigators demonstrated that forkhead box A (FOXA) 2 bound to distinct classes of developmental enhancers in multiple androgen receptor-independent prostate cancer subtypes, with its binding depending on lysine-specific demethylase 1.